Commentary: Needed: A Marshall Plan For VaccinesJohn Carey
For years, Harvard School of Public Health Dean Barry R. Bloom was a voice crying in the wilderness. Doesn't the industrial world care, he wondered, that more than 11 million people are killed each year by malaria, tuberculosis, AIDS, and other major scourges? Or that vaccination rates and life expectancy are falling among many of the world's 2 billion poor people? But his pleas fell mostly on deaf ears. As a result, efforts to develop new vaccines and drugs have been pitifully inadequate.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.